Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients

被引:10
作者
Ye, Xunyan [1 ]
Cabral de Rezende, Wanderson [2 ]
Iwuchukwu, Obinna Patrick [1 ]
Avadhanula, Vasanthi [1 ]
Ferlic-Stark, Laura L. [1 ]
Patel, Kirtida D. [1 ]
Piedra, Felipe-Andres [1 ]
Shah, Dimpy P. [3 ]
Chemaly, Roy F. [4 ,5 ,6 ]
Piedra, Pedro A. [1 ,2 ,7 ]
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Infect Control, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Employee Hlth, Houston, TX 77030 USA
[7] Baylor Coll Med, Dept Pediat, Houston, TX 77003 USA
关键词
respiratory syncytial virus; p27; antibody; hematopoietic cell transplant recipients; HOSPITALIZATIONS; PALIVIZUMAB; PREVENTION; MANAGEMENT; ACTIVATION; CHILDREN; INFANTS;
D O I
10.3390/vaccines8020192
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:Cleavage of the inactive precursor fusion protein (F0) of respiratory syncytial virus (RSV) at two furin-recognition sites is required for membrane fusion activity, and the cleavage releases the twenty-seven amino acid peptide (p27). However, a recent study shows that p27 was an immunodominant epitope in RSV infected children, indicating that p27 was recognized as an immunogen. In the present study, we investigated the immunogenicity of p27 in an immunocompromised population of adults by measuring serum and mucosal antibody responses to p27 in samples from adult hematopoietic cell transplant (HCT) recipients.Methods:We prospectively enrolled a cohort of RSV infected HCT recipients. Serum and nasal-wash samples were obtained within the first week of RSV infection (acute) and 3 to 5 weeks post-infection (convalescent). We quantified the serum and mucosal IgG and IgA anti-p27 antibodies by a RSV/A p27 peptide enzyme-linked immunosorbent assay (ELISA) and serum and mucosal p27 like antibodies (P(27)LA) by a p27 competitive antibody (P(27)CA) assay.Results:The lower limit of detection for the ELISA and P(27)CA assays was 0.2 and 50 ng/mL, respectively with no cross-reaction detected with a panel of monoclonal antibodies targeting pre-fusion and post-fusion antigenic sites. P27 antibodies were detected at nanogram concentration in sera and nasal washes in the majority of RSV infected HCT recipients. However, there was no significant difference in the geometric mean antibody concentrations between the acute and convalescent sera (except for serum P(27)LA), between HCT recipients who shed RSV <14 days and >= 14 days, as well as between RSV/A and RSV/B infected HCT recipients. In addition, approximately 30% of HCT recipients had a 4-fold or greater decrease in mucosal IgG and IgA anti-p27 antibodies during viral clearance.Conclusion:In conclusion, in RSV naturally infected adult HCT recipients, the antibodies against p27 were detectable in both serum and nasal wash samples with higher concentration in serum than that in nasal washes. However, nearly 30% of RSV infected HCT recipients had a significant decrease in their mucosal anti-p27 antibody, suggesting that IgG and IgA anti-p27 antibodies were binding to either free viruses or RSV infected cells containing p27, and that anti-p27 antibodies in the respiratory tract were part of the mucosal antibody response in controlling RSV infection.
引用
收藏
页数:13
相关论文
共 29 条
[21]   CELL-FREE AND CELL-BOUND ANTIBODY IN NASAL SECRETIONS FROM INFANTS WITH RESPIRATORY SYNCYTIAL VIRUS-INFECTION [J].
MCINTOSH, K ;
MCQUILLIN, J ;
GARDNER, PS .
INFECTION AND IMMUNITY, 1979, 23 (02) :276-281
[22]   Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage [J].
Romero, JR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (02) :S46-S54
[23]   Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial [J].
Schwarz, Tino F. ;
McPhee, Roderick A. ;
Launay, Odile ;
Leroux-Roels, Geert ;
Talli, Jaak ;
Picciolato, Marta ;
Gao, Feng ;
Cai, Rongman ;
Thi Lien-Anh Nguyen ;
Dieussaert, Ilse ;
Miller, Jacqueline M. ;
Schmidt, Alexander C. .
JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (11) :1816-1825
[24]   Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997-2006 [J].
Stockman, Lauren J. ;
Curns, Aaron T. ;
Anderson, Larry J. ;
Fischer-Langley, Gayle .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (01) :5-9
[25]  
WHO, VACC PIP TRACK
[26]   Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults [J].
Widmer, Kyle ;
Zhu, Yuwei ;
Williams, John V. ;
Griffin, Marie R. ;
Edwards, Kathryn M. ;
Talbot, H. Keipp .
JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (01) :56-62
[27]   Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults [J].
Ye, Xunyan ;
Iwuchukwu, Obinna P. ;
Avadhanula, Vasanthi ;
Aideyan, Letisha O. ;
McBride, Trevor J. ;
Ferlic-Stark, Laura L. ;
Patel, Kirtida D. ;
Piedra, Felipe-Andres ;
Shah, Dimpy P. ;
Chemaly, Roy F. ;
Piedra, Pedro A. .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[28]   Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients [J].
Ye, Xunyan ;
Iwuchukwu, Obinna P. ;
Avadhanula, Vasanthi ;
Aideyan, Letisha O. ;
McBride, Trevor J. ;
Ferlic-Stark, Laura L. ;
Patel, Kirtida D. ;
Piedra, Felipe-Andres ;
Shah, Dimpy P. ;
Chemaly, Roy F. ;
Piedra, Pedro A. .
JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (08) :1247-1256
[29]   Proteolytic activation of respiratory syncytial virus fusion protein - Cleavage at two furin consensus sequences [J].
Zimmer, G ;
Budz, L ;
Herrler, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31642-31650